<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03396796</url>
  </required_header>
  <id_info>
    <org_study_id>YZUC-003</org_study_id>
    <nct_id>NCT03396796</nct_id>
  </id_info>
  <brief_title>Vagus Nerve-preserving Laparoscopic Splenectomy and Azygoportal Disconnection</brief_title>
  <acronym>ESVLSD</acronym>
  <official_title>Vagus Nerve-preserving Versus Conventional Laparoscopic Splenectomy and Azygoportal Disconnection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yangzhou University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yangzhou University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to evaluate whether vagus nerve-preserving laparoscopic splenectomy and
      azygoportal disconnection is effective and safe, and to determine whether a reduction in the
      incidence of postoperative complications of the digestive system improves postoperative
      quality of life compared with conventional laparoscopic splenectomy and azygoportal
      disconnection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After successful screening the cases of cirrhosis of liver irrespective of the etiology who
      have non tumor portal vein thrombosis will be enrolled. The baseline parameter will be
      recorded and the patient will be randomized into either interventional (vagus
      nerve-preserving laparoscopic splenectomy and azygoportal disconnection) or control
      (conventional laparoscopic splenectomy and azygoportal disconnection) group. From
      postoperative day 3, all patients will receive 100 mg oral aspirin enteric-coated tablets
      (Bayer, Leverkusen, Germany) once daily for 1 year, low-molecular-weight heparin (CS Bio,
      Hebei, China) subcutaneously (4.100 IU/day) for 5 days, and 25 mg of oral dipyridamole (Henan
      Furen, Henan, China) thrice daily for 3 months. At months 3, 9, and 12 after operation,
      electron gastroscopy examination for delayed gastric emptying will be done for all patients.
      Postoperative complications of the digestive system (including diarrhea, epigastric fullness,
      bloating, nausea, and vomiting), liver and renal function, and body weight will be recorded
      at the seventh day, months 1, 3, 6, 9, and 12 after operation. Then one year monitoring will
      be done in the both groups as per the primary or secondary outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 9, 2018</start_date>
  <completion_date type="Anticipated">October 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delayed gastric emptying</measure>
    <time_frame>1 year</time_frame>
    <description>Proportions of patients who will suffer from delayed gastric emptying in both groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications of the digestive system</measure>
    <time_frame>1 year</time_frame>
    <description>Proportions of patients who will suffer from postoperative complications of the digestive system in both groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>1 year</time_frame>
    <description>Proportions of patients who will show improvement in body weight both groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hepatic decompensation</measure>
    <time_frame>1 year</time_frame>
    <description>Proportions of patients who will suffer from hepatic decompensation defined as development of ascites, PSE, portal hypertensive bleeding, jaundice, spontaneous bacterial peritonitis, or systemic infection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Portal vein system thrombosis</measure>
    <time_frame>1 year</time_frame>
    <description>Proportions of patients who will suffer from portal vein system thrombosis in both groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hepatocellular carcinoma</measure>
    <time_frame>1 year</time_frame>
    <description>Proportions of patients who will suffer from hepatocellular carcinoma in both groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>1 year</time_frame>
    <description>Overall survival in both groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Hypertension</condition>
  <condition>Splenectomy</condition>
  <condition>Laparoscopy</condition>
  <arm_group>
    <arm_group_label>Vagus nerve-preserving group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Every patient of vagus nerve-preserving group will receive the modified vagus nerve-preserving laparoscopic azygoportal disconnection procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Every patient of conventional group will receive the conventional laparoscopic azygoportal disconnection procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vagus nerve-preserving group</intervention_name>
    <description>The modified vagus nerve-preserving procedure was performed in the following order: (1) left gastroepiploic vein along greater curvature; (2) the posterior surface of stomach, including the posterior gastric veins; (3) the left lateral surface of the distal esophagus; (4) the left inferior phrenic veins; (5) the posterior surface of the distal esophagus;(6) the anterior surface of the distal esophagus; and (7) the right lateral surface of the distal esophagus. The hepatogastric ligament was conserved. the adherent junction between visceral peritoneum and the right crural diaphragm, and divided it into the lesser omental sac. The left gastric artery and vein and the posterior gastric veins were transected en bloc using a linear laparoscopic vascular stapler.</description>
    <arm_group_label>Vagus nerve-preserving group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A clinical, radiological or histologic diagnosis of cirrhosis of any etiology

          -  Splenomegaly with secondary hypersplenism

          -  Bleeding portal hypertension

          -  No evidence of portal vein system thrombosis by ultrasound evaluation and angio-CT

          -  Informed consent to participate in the study

        Exclusion Criteria:

          -  Delayed gastric emptying

          -  Diarrhea

          -  Hepatocellular carcinoma or any other malignancy,

          -  Hypercoagulable state other than the liver disease related

          -  DRUGS- oral contraceptives, anticoagulation or anti-platelet drugs.

          -  Child - Pugh C

          -  Recent peptic ulcer disease

          -  History of Hemorrhagic stroke

          -  Pregnancy.

          -  Uncontrolled Hypertension

          -  Age&gt;75 yrs

          -  Human immunodeficiency virus (HIV) infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dou-Sheng Bai, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical Medical College of Yangzhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guo-Qing Jiang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Medical College of Yangzhou University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ping Chen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Clinical Medical College of Yangzhou University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guo-Qing Jiang, MD</last_name>
    <phone>86-514-87373272</phone>
    <email>jgqing2003@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dou-sheng Bai, MD</last_name>
    <phone>86-514-87373275</phone>
    <email>bdsno1@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical Medical College of Yangzhou University</name>
      <address>
        <city>Yangzhou</city>
        <state>Jiangsu</state>
        <zip>225001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guo-Qing Jiang, MS</last_name>
      <phone>86-514-87373372</phone>
      <email>jgqing2003@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Dou-Sheng Bai, MD</last_name>
      <phone>86-514-87373375</phone>
      <email>bdsno1@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Guo-Qing Jiang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sheng-Jie Jin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2018</study_first_submitted>
  <study_first_submitted_qc>January 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 11, 2018</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yangzhou University</investigator_affiliation>
    <investigator_full_name>Guo-Qing Jiang</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Vagus nerve</keyword>
  <keyword>Delayed gastric emptying</keyword>
  <keyword>Cirrhosis</keyword>
  <keyword>Hypertension</keyword>
  <keyword>laparoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

